These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Treves S; Anderson AA; Ducreux S; Divet A; Bleunven C; Grasso C; Paesante S; Zorzato F Neuromuscul Disord; 2005 Oct; 15(9-10):577-87. PubMed ID: 16084090 [TBL] [Abstract][Full Text] [Related]
6. Molecular basis of inherited calcium channelopathies: role of mutations in pore-forming subunits. McKeown L; Robinson P; Jones OT Acta Pharmacol Sin; 2006 Jul; 27(7):799-812. PubMed ID: 16787562 [TBL] [Abstract][Full Text] [Related]
7. Ion channels-related diseases. Dworakowska B; Dołowy K Acta Biochim Pol; 2000; 47(3):685-703. PubMed ID: 11310970 [TBL] [Abstract][Full Text] [Related]
8. [Intracellular calcium: physiology and physiopathology]. Missiaen L; Callewaert G; Parys JB; Wuytack F; Raeymaekers L; Droogmans G; Nilius B; Eggermont J; De Smedt H Verh K Acad Geneeskd Belg; 2000; 62(6):471-99. PubMed ID: 11196578 [TBL] [Abstract][Full Text] [Related]
9. The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Zucchi R; Ronca-Testoni S Pharmacol Rev; 1997 Mar; 49(1):1-51. PubMed ID: 9085308 [No Abstract] [Full Text] [Related]
10. Calcium channelopathies in inherited neurological disorders: relevance to drug screening for acquired channel disorders. Lory P; Mezghrani A IDrugs; 2010 Jul; 13(7):467-71. PubMed ID: 20582871 [TBL] [Abstract][Full Text] [Related]
11. [Physiopathology of calcium channels: identification of calcium channelopathies]. Lory P; Monteil A C R Seances Soc Biol Fil; 1998; 192(1):137-47. PubMed ID: 9759359 [TBL] [Abstract][Full Text] [Related]
12. Early onset, non fluctuating spinocerebellar ataxia and a novel missense mutation in CACNA1A gene. Tonelli A; D'Angelo MG; Salati R; Villa L; Germinasi C; Frattini T; Meola G; Turconi AC; Bresolin N; Bassi MT J Neurol Sci; 2006 Feb; 241(1-2):13-7. PubMed ID: 16325861 [TBL] [Abstract][Full Text] [Related]
13. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies. Flink MT; Atchison WD J Bioenerg Biomembr; 2003 Dec; 35(6):697-718. PubMed ID: 15000529 [TBL] [Abstract][Full Text] [Related]
14. Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies. Dutch Migraine Genetics Research Group. Terwindt GM; Ophoff RA; Haan J; Sandkuijl LA; Frants RR; Ferrari MD Eur J Hum Genet; 1998; 6(4):297-307. PubMed ID: 9781035 [TBL] [Abstract][Full Text] [Related]
15. [Channelopathies in neurology]. Grippo J; Grippo T Rev Neurol; 2001 Oct 1-15; 33(7):643-7. PubMed ID: 11784953 [TBL] [Abstract][Full Text] [Related]
16. Neuromuscular disease and calcium channels. Greenberg DA Muscle Nerve; 1999 Oct; 22(10):1341-9. PubMed ID: 10487899 [TBL] [Abstract][Full Text] [Related]
17. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis. Takamori M J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248 [TBL] [Abstract][Full Text] [Related]
19. Expression and cellular localization of a modified type 1 ryanodine receptor and L-type channel proteins in non-muscle cells. Lee BS; Sessanna S; Laychock SG; Rubin RP J Membr Biol; 2002 Oct; 189(3):181-90. PubMed ID: 12395283 [TBL] [Abstract][Full Text] [Related]